鼻窦癌预后因素:多中心汇总分析
该多中心汇总分析回顾了376例非转移性鼻窦癌(M0-SNC)患者的电子健康记录,采用多变量分析计算组织学类型(以鳞状细胞癌为对照)、T/N分期及原发治疗方式对局部区域失败、远处转移和死亡风险的调整风险比。结果显示不同组织学类型呈现不同的复发和生存模式,提示需要不同的管理策略。
要点
- 黏膜黑色素瘤、T3-4期和淋巴结受累与更高的死亡风险独立相关。
- 黏膜黑色素瘤、腺样囊性癌和SNUC/SNEC组织学及T3-4期与更高的远处转移风险相关。
- T3-4期和淋巴结受累与更高的局部区域失败风险相关,而SNUC/SNEC组织学与更低的局部区域失败风险相关。
核心结论
- 不同鼻窦癌组织学类型表现出不同的复发和生存模式,突出表明需要不同的管理策略。
研究设计与样本
- 回顾性多中心汇总分析,纳入两家三级机构收治的376例接受根治性手术±术后放疗或放化疗的M0-SNC患者。
- 对鳞状细胞癌亚组进行p16染色;采用多变量分析计算组织学类型(以SCC为对照)、T/N分期及原发治疗方式对局部区域失败、远处转移和死亡风险的调整风险比(aHR)。
主要发现
- 黏膜黑色素瘤组织学(aHR 2.03,95% CI 21.23-3.33)、年龄较大(aHR 1.02;95% CI:1.00-1.03)、T3-4肿瘤(aHR 5.08,95% CI 2.77-9.30)和淋巴结受累(aHR:2.15,95% CI 1.46-3.16)与更高的死亡风险相关(均p < 0.05)。
- 黏膜黑色素瘤(aHR 10.14,95% CI 4.90-21.01)、腺样囊性癌(aHR 2.97,95% CI 1.27-6.96)和SNUC/SNEC组织学(aHR 6.80,95% CI 3.30-14.01)以及T3-4类别(对比T1-2,HR 4.79,95% CI 1.53-14.95)与更高的远处转移风险相关。
- T3-4(aHR 2.33,95% CI 1.37-3.97)和淋巴结受累(aHR 1.70,95% CI 1.11-2.60)与更高的局部区域失败风险相关,而SNUC/SNEC组织学与更低的局部区域失败风险相关(aHR 0.51,95% CI 0.26-3.33)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Sinonasal cancers (SNC) are heterogeneous diseases with different clinical behavior. We aimed to identify prognostic factors in non-metastatic (M0)-SNC. METHODS: Electronic health records from M0-SNC patients treated with definitive surgery ± postoperative radiotherapy or chemoradiotherapy at two tertiary institutions were reviewed. p16 staining was performed in the squamous cell carcinoma (SCC) subset. Multivariable analysis (MVA) calculated the adjusted hazard ratio (aHR) for histology type (SCC as the comparator), T/N categories, and primary treatment modality for the risk of locoregional failure (LRF), distant metastasis (DM), and deaths. RESULTS: A total of 376 patients were eligible including 209 (56%) SCC (p16+: 35; p16-/untested: 157), 42 (11%) adenocarcinoma, 35 (9%) sinonasal undifferentiated carcinoma or sinonasal neuroendocrine tumors (SNUC/SNEC), 33 (9%) mucosal melanoma (MM), 30 (8%) esthesioneuroblastoma (ES), and 27 (7%) adenoid cystic carcinoma (ACC). MVA identified MM histology (aHR 2.03, 95% CI 21.23-3.33), older age (aHR 1.02; 95% CI: 1.00-1.03), T3-4 tumor (aHR 5.08, 95% CI 2.77-9.30), and nodal involvement (aHR: 2.15, 95% CI 1.46-3.16) carried higher mortality risk (all p < 0.05); MM (aHR 10.14, 95% CI 4.90-21.01), ACC (aHR 2.97, 95% CI 1.27-6.96), and SNUC/SNEC (aHR 6.80, 95% CI 3.30-14.01) histologies and T3-4 categories (vs. T1-2, HR 4.79, 95% CI 1.53-14.95) had higher DM risk; T3-4 (aHR 2.33, 95% CI 1.37-3.97) and nodal involvement (aHR 1.70, 95% CI 1.11-2.60) conveyed higher LRF risk while SNUC/SNEC histologies had a lower LRF risk (aHR 0.51, 95% CI 0.26-3.33). CONCLUSIONS: Different SNC histology types exhibit distinct patterns of relapse and survival, highlighting the need for different management strategies.
引用
- Stefanovic M, Hernando-Calvo A, Castro JB, et al. Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis. Laryngoscope. 2025. PMID: 40856008. doi:10.1002/lary.70044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。